Strategy files Form 8-K
Strategy filed a Form 8-K on October 28.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
30 results loaded, newest first. More results are available. The latest changes are still being indexed. Try again shortly for updated results.
IP Strategy Holdings files Form 8-K
IP Strategy Holdings filed a Form 8-K on October 27.
Strategy files Form 8-K for Oct. 26
Strategy filed a Form 8-K on October 26.
F N B Q3 2026 Earnings Call Transcript
F N B (NYSE: FNB ) reported third-quarter financial results on Tuesday. The transcript from the company's third-quarter earnings call has been provided below. This transcript is brought to you APIs. For real-time access to our entire catalog, please visit for a consultation. View the webcast at Summary F N B Corporatio
First Horizon Reports Q3 Adjusted EPS of $0.53, Plans $4.5 Billion Mortgage Sale
First Horizon reported adjusted third-quarter EPS of $0.53 and said it agreed in October to sell about $4.5 billion of residential mortgage loans, with settlement expected early in the fourth quarter. The bank expects the sale to add about 4% to EPS in 2027, excluding potential benefits from redeploying proceeds.
Dropbox Reports Q2 Results, Announces $900 Million Buyback Authorization
Dropbox reported positive year-over-year revenue growth, added 96,000 paying users for a third consecutive quarter and posted a 39.7% non-GAAP operating margin. The company authorized a new $900 million share repurchase program and forecast fiscal 2026 revenue in a stated range.
Artelo Biosciences Files 8K - Other Events >ARTL
Artelo Biosciences Inc. (ARTL) filed a Form 8K - Other Events - with the U.S Securities and Exchange Commission on October 09, 2026. On July 22, 2026, the Securities and Exchange Commission (the "SEC") approved The Nasdaq Stock Market LLC's ("Nasdaq") new listing compliance rule that requires listed companies to mainta
BioRestorative Therapies files 8-K on director appointment
BioRestorative Therapies said its board appointed Donald J. Currie as a Class I director, effective immediately, to fill a vacancy. It also named him to the Nominating and Corporate Governance Committee and the Compensation Committee.
Atossa Therapeutics files 8-K on CVR agreement
Atossa Therapeutics filed an 8-K describing a definitive agreement tied to stapled contingent value rights. The rights are linked to any future priority review voucher monetization and are capped at $50 million.
Stride files 8-K on cooperation agreement, board changes
Stride said it entered a cooperation agreement, appointed Mr. Haggart to its board and named Dr. Guttentag as board observer. The company also formed a Capital Allocation Committee and said it expects to announce a target capital structure after the committee’s initial review.
Marwynn Holdings files 8-K on evaluation pact
Marwynn Holdings said it entered a memorandum of understanding with OmniX Technologies to evaluate potential cooperation in AI and high-performance computing, RWA infrastructure, and related market development matters. The filing says the MOU is largely nonbinding and does not commit either party to a transaction.
Quince Therapeutics files 8-K on director changes
Quince Therapeutics said several directors resigned from its board and named four new directors effective Oct. 8, 2026. The filing also disclosed compensation terms for Keith R. Fandrick.
GigCapital8 files 8-K on merger agreement
GigCapital8 said it entered into a merger agreement with Quantisimo Holdings, WISeQey and SealSQ on Oct. 8 and disclosed the deal in an 8-K filing.
Velo3D files 8-K on CEO social media post
Velo3D said it filed an 8-K covering a social media post by Chief Executive Officer Arun Jeldi about the company’s financial outlook and guidance. The filing says the post addresses revenue guidance, customer relationships and expected performance through year-end 2026.
Hess Midstream files Form 8-K on proposed transaction
Hess Midstream filed a Form 8-K with the SEC on Oct. 8, 2026. The filing includes forward-looking statements tied to a proposed transaction and related tax implications.
Braemar Hotels files 8-K on portfolio update, outlook
Braemar Hotels & Resorts filed an 8-K disclosing a press release on a portfolio update and 2027 financial outlook. The filing also says the company made an investor presentation available.
Braemar Hotels & Resorts files 8-K on settlement deal
Braemar Hotels & Resorts said it entered a cooperation and settlement agreement with Al Shams Investments and others, under which the investor withdrew board nomination notices and agreed to standstill and voting commitments. Braemar said it expects its total contribution to be $4 million to $6 million after insurance
Diamondback Energy files 8-K on quarterly prices
Diamondback Energy said in an 8-K that third-quarter realized oil prices were $87.30 per barrel unhedged and $85.89 hedged. It also disclosed anticipated derivative losses of $97 million in cash settlements and $85 million in non-cash losses.
PepsiCo cuts full-year outlook on North America weakness
PepsiCo cut its full-year earnings outlook as inflation, higher advertising costs and continued weakness in North America weighed on results. The company said it is working to reduce expenses and revive sales.
JLL Income Property Trust files 8-K disclosure
JLL Income Property Trust filed a Form 8-K Regulation FD disclosure with the SEC and said it closed a $68.5 million mortgage loan secured by Whitestown Distribution Center IV. The loan has a seven-year term and a 5.54% interest rate.
Vylor Files 8K - Director, Officer or Compensation Filing >VYLR
Vylor Inc. (VYLR) filed a Form 8K - Director, Officer or Compensation Filing - with the U.S Securities and Exchange Commission on October 07, 2026. Appointment and Resignation of Directors On September 24, 2026, when the Company's Registration Statement on Form 10, initially filed with the U.S. Securities and Exchange
Aperture AC Files 8K - Regulation FD >APUR -2
network difficulty may adversely affect Atlantic's mining revenue and profitability; Atlantic's dependence on a single mining pool operator for substantially all of its mining revenue, and the ability of the pool operator to adjust fee rates; Atlantic's AI/HPC infrastructure business has not generated material revenue
BKV Files 8K - Regulation FD >BKV
BKV Corp. (BKV) filed a Form 8K - Regulation FD Disclosure - with the U.S Securities and Exchange Commission on October 07, 2026. On October 7, 2026, BKV issued a press release announcing the entry into the Supply Contract. A copy of the press release is furnished with this Current Report on Form 8-K as Exhibit 99.1. T
Full Transcript: Ligand Pharmaceuticals Q2 2026 Earnings Call
On Thursday, Ligand Pharmaceuticals (NASDAQ: LGND ) discussed second-quarter financial results during its earnings call. The full transcript is provided below. APIs provide real-time access to earnings call transcripts and financial data. Visit to learn more. The full earnings call is available at Summary Full Transcri
Altius Minerals Corporation Files Early Warning Report
For best results when printing this announcement, please click on link below: Altius Minerals Corporation Files Early Warning Report Not For Dissemination In The United States Or To United States Newswire Services Altius Minerals Corporation (ALS:TSX) (ATUSF: OTCQX) (“Altius” or the “Corporation”) announces today that
Delcath Systems Q2 2026 Earnings Call Transcript
Delcath Systems (NASDAQ: DCTH ) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. APIs provide real-time access to earnings call transcripts and financial data. Visit to learn more. Access the full call at Summary Delcath Syste
Formycon integrates AI and digital solutions to enhance biosimilar development efficiency
Formycon AG is incorporating AI and digital technologies into its biosimilar development processes, aiming to optimize workflows and create sustainable value. The company is implementing PhlexTMF Enterprise, an electronic trial master file solution with AI-assisted capabilities, and an AI-powered software for analyzing
HomeTrust Bancshares authorizes new 5% stock repurchase program
HomeTrust Bancshares Inc. has completed its previous 5% stock repurchase program, buying back 832,000 shares at an average price of $47.70. The company's board has authorized a new program to repurchase up to an additional 790,000 shares, representing approximately 5% of outstanding stock.
Oscar Health Q2 2026 Earnings Call: Complete Transcript
Oscar Health (NYSE: OSCR ) held its second-quarter earnings conference call on Thursday. Below is the complete transcript from the call. This transcript is brought to you APIs. For real-time access to our entire catalog, please visit for a consultation. The full earnings call is available at Summary Oscar Health report
SUI Group to sponsor Sui Basecamp 2026 as platinum sponsor
SUI Group Holdings Limited said it will be a platinum sponsor of Sui Basecamp 2026 in Singapore on October 7-8. Board Director Brian Quintenz will speak at the event, which will feature a live trading competition on the SUIG Arena stage.